The findings further bolster the idea that this class of medication can also be used to reduce people’s unhealthy dependence on drugs like cocaine and alcohol. Semaglutide and other newer GLP-1 ...

Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of worsening kidney disease in people with type 2 diabetes. The approval ...

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...

MEDVi, a cutting-edge telehealth weight loss program, aims to simplify and enhance weight management through FDA-approved GLP-1 medications. With a science-backed approach, MEDVi offers ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based medical technology enterprise, was recently approved for market by China's ...

“These exorbitant costs have made it extremely challenging to be able to continue to provide drug coverage to everyone who wants these drugs but does not have an FDA-approved medical condition ...